Clinical outcomes of variceal and non-variceal upper gastrointestinal bleeding in patients with liver cirrhosis
Comparison of hepatitis B reactivation in patients with resolved hepatitis B infection receiving rituximab or non-rituximab based immunosuppressive therapy. Does the presence of hepatitis b surface antibody reduce risk of reactivation?
Acute on Chronic Liver failure is associated with prolonged clot initiation in Rotational Thromboelastometry as compared to Acute Decompensation, but clot formation time and firmness are similar.
Improving Validity of Hepatic Venous Pressure Gradient Measurements (Hvpg): A Quality Improvement Project
Effectiveness of ReLink Initiatives to Re-engage Diagnosed-but-Untreated HCV-Positive Patients with Direct-Acting Antiviral Treatment
Physicians, Case Managers, and HCV Patients Recommend a Simplified Strategy for Baseline Testing and Minimal Monitoring for Treatment of Hepatitis C Virus Infection with DAA Therapies
The Role of Renal Impairment on Rotational Thromboelastometry (Rotem) Parameters in Hospitalised Patients with Cirrhosis a Prospective Cohort Study
Assessing the Impact of Direct-acting Antivirals on Hepatitis C Complications: A Systematic Review and Meta-analysis
Integrating Viral Hepatitis into Primary Health Care: A Landscape Analysis of the Current State of the Philippines
Optimisation of methodologies for comprehensive screening of host proteins binding to Hepatitis B virus X protein
Efficacy and Safety of Bulevirtide Monotherapy Given at 2 mg or 10 mg Dose Level Once Daily for Treatment of Chronic Hepatitis Delta: Week 48 Primary Endpoint Results From a Phase 3 Randomized, Multicenter, Parallel Design Study
Meld 3.: An Updated Model for Prediction of Mortality Amongst Patients with Cirrhosis Validated in a Large Tertiary Hospital in Singapore
